Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epidemiology of hepatitis C virus infection among people receiving opioid substitution therapy (ECHO): study protocol.

BMC infectious diseases - 10 Dec 2015

Strada Lisa, Schulte Bernd, Schmidt Christiane Sybille, Verthein Uwe, Cremer-Schaeffer Peter, Krückeberg Sabine, Reimer Jens

Abstract excerpt

BACKGROUND: Hepatitis C virus infection is highly prevalent among people who inject drugs. Opioid substitution therapy, the standard treatment for opioid dependence, provides an excellent opportunity for the treatment of hepatitis C virus infection due to the close and regular contact between patients and clinicians. However, there is little research on the impact of opioid substitution therapy on the prevalence...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Analgesics, Opioid
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germany

Share to Hepacivirus

Share to Hepatitis C

Share to Longitudinal Studies

Share to Prevalence

Share to Substance Abuse, Intravenous

Source

Open in PubMed Open full text

Identifiers

PMID: 26653754
DOI: 10.1186/s12879-015-1307-z
PMCID: PMC4676160

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epidemiology of hepatitis C virus infection among people receiving opioid substitution therapy (ECHO): study protocol.PMID 26653754Read ↗

On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017Semantic proximity Read ↗

Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: A systematic review updateSemantic proximity Read ↗

Impact of recent drug use on the efficacy of elbasvir/grazoprevir for HCV-infected people on opioid agonist therapy.Semantic proximity Read ↗

Treatment of hepatitis C virus infection in people with opioid use disorder: a real-world study of elbasvir/grazoprevir in a US Department of Veterans Affairs population.Semantic proximity Read ↗

Efficacy of peginterferon plus ribavirin in patients receiving opioid substitution therapy : Final results of the Austrian PegHope study.Semantic proximity Read ↗

Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial.Semantic proximity Read ↗

Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials.Semantic proximity Read ↗

Elbasvir/grazoprevir for the treatment of hepatitis C virus infection in people with opioid use disorder.Semantic proximity Read ↗

[Hepatitis C and drug use: epidemiology, screening, natural history and treatment].Semantic proximity Read ↗

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.Semantic proximity Read ↗

Management of hepatitis C virus (HCV) infection in drug substitution programs.Semantic proximity Read ↗

Global genotype distribution of hepatitis C viral infection among people who inject drugs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.